...
aplt-img

Applied Therapeutics Inc, Common Stock

APLT

NMQ

$0.8801

-$0.14

(-13.73%)

1D
Industry: Biotechnology Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$125.66M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
14.11M
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
2.02
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$0.84 L
$10.62 H
$0.8801

About Applied Therapeutics Inc, Common Stock

Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need in the United States. The company's lead product candidate is AT-007 (also called govorestat) that has completed phase 3 for the treatment of galactosemia in healthy volunteers and adults, in pediatric clinical study for the treatment of galactosemia in kids, for treating enzyme sorbitol dehydrogenase, and for the treatment of phosphomannomutase enzyme-CDG. It also develops AT-001 (also called caficrestat) that is in phase 3 clinical trials to treat diabetic cardiomyopathy, as well as for the treatment of diabetic peripheral neuropathy; and AT-003, which is in preclinical studies for the treatment diabetic retinopathy. The company has exclusive license and supply agreement with Mercury Pharma Group Limited to commercialize drug products containing AT-007. Applied Therapeutics, Inc. was incorporated in 2016 and is headquartered in New York, New York. more

Industry: BiotechnologySector: Health Care

Returns

Time FrameAPLTSectorS&P500
1-Week Return-23.47%-2.12%-3%
1-Month Return-90.67%-3.42%-0.73%
3-Month Return-88.57%-11.13%2.87%
6-Month Return-80.22%-5.74%7.17%
1-Year Return-70.27%3.97%25.31%
3-Year Return-90.68%1.05%28.38%
5-Year Return-96.44%34.37%81.89%
10-Year Return-90.64%97.88%183.27%

Financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue---10.66M9.99M[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":93.74,"profit":true}]
Cost of Revenue23.00K380.00K415.00K441.00K353.00K[{"date":"2019-12-31","value":5.22,"profit":true},{"date":"2020-12-31","value":86.17,"profit":true},{"date":"2021-12-31","value":94.1,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":80.05,"profit":true}]
Gross Profit(23.00K)(380.00K)(415.00K)(441.00K)9.64M[{"date":"2019-12-31","value":-0.24,"profit":false},{"date":"2020-12-31","value":-3.94,"profit":false},{"date":"2021-12-31","value":-4.3,"profit":false},{"date":"2022-12-31","value":-4.57,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]
Gross Margin---(4.14%)96.47%[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":-4.29,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]
Operating Expenses45.58M94.47M105.62M82.95M74.53M[{"date":"2019-12-31","value":43.16,"profit":true},{"date":"2020-12-31","value":89.44,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":78.54,"profit":true},{"date":"2023-12-31","value":70.56,"profit":true}]
Operating Income(45.58M)(94.47M)(105.62M)(82.95M)(64.53M)[{"date":"2019-12-31","value":-4558200000,"profit":false},{"date":"2020-12-31","value":-9446600000,"profit":false},{"date":"2021-12-31","value":-10561800000,"profit":false},{"date":"2022-12-31","value":-8295000000,"profit":false},{"date":"2023-12-31","value":-6453500000,"profit":false}]
Total Non-Operating Income/Expense162.00K1.06M589.00K1.13M(53.86M)[{"date":"2019-12-31","value":14.37,"profit":true},{"date":"2020-12-31","value":94.41,"profit":true},{"date":"2021-12-31","value":52.26,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-4778.7,"profit":false}]
Pre-Tax Income(45.51M)(93.96M)(105.58M)(82.51M)(119.76M)[{"date":"2019-12-31","value":-4551300000,"profit":false},{"date":"2020-12-31","value":-9396100000,"profit":false},{"date":"2021-12-31","value":-10558400000,"profit":false},{"date":"2022-12-31","value":-8250800000,"profit":false},{"date":"2023-12-31","value":-11976300000,"profit":false}]
Income Taxes(116.00K)(939.00K)(970.00K)(819.00K)185.10K[{"date":"2019-12-31","value":-62.67,"profit":false},{"date":"2020-12-31","value":-507.28,"profit":false},{"date":"2021-12-31","value":-524.03,"profit":false},{"date":"2022-12-31","value":-442.45,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]
Income After Taxes(45.40M)(93.02M)(104.61M)(81.69M)(119.95M)[{"date":"2019-12-31","value":-4539700000,"profit":false},{"date":"2020-12-31","value":-9302200000,"profit":false},{"date":"2021-12-31","value":-10461400000,"profit":false},{"date":"2022-12-31","value":-8168900000,"profit":false},{"date":"2023-12-31","value":-11994810500,"profit":false}]
Income From Continuous Operations(45.51M)(93.96M)(105.58M)(82.51M)(119.76M)[{"date":"2019-12-31","value":-4551300000,"profit":false},{"date":"2020-12-31","value":-9396100000,"profit":false},{"date":"2021-12-31","value":-10558400000,"profit":false},{"date":"2022-12-31","value":-8250800000,"profit":false},{"date":"2023-12-31","value":-11976300000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income(45.40M)(93.02M)(104.61M)(81.69M)(119.76M)[{"date":"2019-12-31","value":-4539700000,"profit":false},{"date":"2020-12-31","value":-9302200000,"profit":false},{"date":"2021-12-31","value":-10461400000,"profit":false},{"date":"2022-12-31","value":-8168900000,"profit":false},{"date":"2023-12-31","value":-11976300000,"profit":false}]
EPS (Diluted)(4.38)(4.25)(4.12)(2.24)(1.36)[{"date":"2019-12-31","value":-438,"profit":false},{"date":"2020-12-31","value":-425,"profit":false},{"date":"2021-12-31","value":-412,"profit":false},{"date":"2022-12-31","value":-224,"profit":false},{"date":"2023-12-31","value":-136,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

APLT
Cash Ratio 1.00
Current Ratio 1.06

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

APLT
ROA (LTM) -76.01%
ROE (LTM) -473.39%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

APLT
Debt Ratio Lower is generally better. Negative is bad. 0.94
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.06

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

APLT
Trailing PE NM
Forward PE NM
P/S (TTM) 54.68
P/B 17.38
Price/FCF NM
EV/R 62.37
EV/Ebitda NM

FAQs

What is Applied Therapeutics Inc share price today?

Applied Therapeutics Inc (APLT) share price today is $0.8801

Can Indians buy Applied Therapeutics Inc shares?

Yes, Indians can buy shares of Applied Therapeutics Inc (APLT) on Vested. To buy Applied Therapeutics Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in APLT stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Applied Therapeutics Inc be purchased?

Yes, you can purchase fractional shares of Applied Therapeutics Inc (APLT) via the Vested app. You can start investing in Applied Therapeutics Inc (APLT) with a minimum investment of $1.

How to invest in Applied Therapeutics Inc shares from India?

You can invest in shares of Applied Therapeutics Inc (APLT) via Vested in three simple steps:

  • Click on Sign Up or Invest in APLT stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Applied Therapeutics Inc shares
What is Applied Therapeutics Inc 52-week high and low stock price?

The 52-week high price of Applied Therapeutics Inc (APLT) is $10.62. The 52-week low price of Applied Therapeutics Inc (APLT) is $0.84.

What is Applied Therapeutics Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Applied Therapeutics Inc (APLT) is

What is Applied Therapeutics Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Applied Therapeutics Inc (APLT) is 17.38

What is Applied Therapeutics Inc dividend yield?

The dividend yield of Applied Therapeutics Inc (APLT) is 0.00%

What is the Market Cap of Applied Therapeutics Inc?

The market capitalization of Applied Therapeutics Inc (APLT) is $125.66M

What is Applied Therapeutics Inc’s stock symbol?

The stock symbol (or ticker) of Applied Therapeutics Inc is APLT

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top